Abstract
1195P - Alterations in peripheral T cell subsets, T cell activation markers and immune checkpoint molecules in advanced pancreatic cancer patients receiving FOLFIRINOX or gemcitabine + nab-paclitaxel
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have